These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1378324)

  • 1. Molecular breakpoints and platelet counts in chronic myeloid leukemia.
    Shepherd PC; Bond C; Allan NC
    Blood; 1992 Jul; 80(2):556-7. PubMed ID: 1378324
    [No Abstract]   [Full Text] [Related]  

  • 2. No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia.
    Opalka B; Wandl UB; Stutenkemper R; Kloke O; Seeber S; Niederle N
    Blood; 1992 Oct; 80(7):1854-5. PubMed ID: 1391949
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Futaki M; Dan K; Nomura T
    Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2).
    Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Trabacchi E; Saglio G; Tura S
    Leukemia; 1999 Oct; 13(10):1635-7. PubMed ID: 10516770
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of reverse BCR/ABL gene rearrangement in Ph-negative chronic myelogenous leukemia.
    Verma RS; Chandra P
    Leuk Res; 2000 Jul; 24(7):631-5. PubMed ID: 10867140
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Nomura T
    Leuk Lymphoma; 1993 May; 10(1-2):9-15. PubMed ID: 8374529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival.
    Shepherd P; Suffolk R; Halsey J; Allan N
    Br J Haematol; 1995 Mar; 89(3):546-54. PubMed ID: 7734353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative MR
    Cerveira N; Diamond J; Matos S; Amorim ML; Coucelo M; Bizarro S; Simões AT; Pierdomenico F; Lopes M; Ribeiro L; do Carmo-Fonseca M; Guimarães JE; Almeida A; Teixeira MR
    Br J Haematol; 2019 Sep; 186(6):e181-e184. PubMed ID: 31218669
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare, in-frame BCR-ABL fusion (e13a3) in a patient with an aggressive chronic myeloid leukaemia.
    Otazú IB; Belén Rivero M; Olício R; Pinto A; Zalcberg I; Seuánez HN
    Acta Haematol; 2002; 108(3):150-3. PubMed ID: 12373087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Inoue T; Tojo A; Futaki M; Miyake K; Yamada T; Tanabe Y; Ohki I; Dan K; Ozawa K
    Blood; 1991 Dec; 78(12):3125-7. PubMed ID: 1742479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia.
    Yamagata T; Mitani K; Kanda Y; Yazaki Y; Hirai H
    Br J Haematol; 1996 Aug; 94(2):370-2. PubMed ID: 8759898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New breakpoints of t(9;22) translocation in chronic myeloid leukemia].
    Misiurin AV; Surin VL; Tagiev AF
    Bioorg Khim; 1999 Mar; 25(3):234-6. PubMed ID: 10382043
    [No Abstract]   [Full Text] [Related]  

  • 14. The e19a2 BCR/ABL fusion transcript with additional chromosomal aberrations on a new case of chronic myeloid leukemia (CML) of mild type.
    Bertorelle R; Bonaldi L; Bianchini E; Ramazzina E; Del Mistro A; Zamboni S; Chieco-Bianchi L; Paolini R
    Leukemia; 2001 Dec; 15(12):2003-4. PubMed ID: 11753631
    [No Abstract]   [Full Text] [Related]  

  • 15. Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib.
    Mulas O; Caocci G; Annunziata M; Martino B; Luciano L; Castagnetti F; Pregno P; Galimberti S; Albano F; Orlandi EM; Sgherza N; Iurlo A; Bonifacio M; Binotto G; Gozzini A; Bocchia M; Abruzzese E; Fozza C; Simula MP; De Gregorio F; Gugliotta G; Pirillo F; Baratè C; Attolico I; Elena C; Cattaneo D; Scaffidi L; Sicuranza A; Trawinska MM; Scalzulli E; Foà R; Breccia M; La Nasa G
    Hematol Oncol; 2020 Oct; 38(4):607-610. PubMed ID: 32602167
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
    Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of p210 BCR-ABL transcript variants with clinical, parameters and disease outcome in 45 chronic myeloid leukemia patients.
    Al-Achkar W; Moassass F; Youssef N; Wafa A
    J BUON; 2016; 21(2):444-9. PubMed ID: 27273956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the BCR-ABL fusion gene in natural killer cells in patients with chronic myelogenous leukemia.
    Min CK; Yang IH; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Acta Haematol; 2000; 104(2-3):135-8. PubMed ID: 11154991
    [No Abstract]   [Full Text] [Related]  

  • 19. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukaemia: a therapeutic challenge.
    Mughal TI; Goldman JM
    Ann Oncol; 1995 Sep; 6(7):637-44. PubMed ID: 8664183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.